Neuroprotective Effects of Asparagus officinalis Stem Extract in Transgenic Mice Overexpressing Amyloid Precursor Protein

被引:3
|
作者
Peng, Zhanglong [1 ]
Bedi, Supinder [2 ]
Mann, Vivek [3 ]
Sundaresan, Alamelu [3 ]
Homma, Kohei [4 ]
Gaskey, Gregory [1 ]
Kowada, Minoru [5 ]
Umar, Shahid [6 ]
Kulkarni, Anil D. [5 ]
Eltzschig, Holger K. [1 ]
Doursout, Marie-Francoise [1 ]
机构
[1] McGovern Med Houston, Dept Anesthesiol, Houston, TX USA
[2] McGovern Med Houston, Pediat Surg, Houston, TX USA
[3] Texas Southern Univ, Dept Biol, Houston, TX 77004 USA
[4] Amino Up, Sapporo, Hokkaido, Japan
[5] McGovern Med Houston, Gen Surg, Houston, TX USA
[6] Univ Kansas, Dept Surg, Kansas City, KS USA
关键词
HEAT-SHOCK-PROTEIN; ALZHEIMERS-DISEASE; APOPTOSIS; STRESS; BETA; EXPRESSION; BRAIN; HEAT-SHOCK-PROTEIN-70; INDUCTION; LOCALIZATION;
D O I
10.1155/2021/8121407
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To mimic Alzheimer's disease, transgenic mice overexpressing the amyloid precursor protein (APP) were used in this study. We hypothesize that the neuroprotective effects of ETAS (R) 50, a standardized extract of Asparagus officinalis stem produced by Amino Up Co., Ltd. (Sapporo, Japan), are linked to the inhibition of the apoptosis cascade through an enhancement of the stress-response proteins: heat shock proteins (HSPs). APP-overexpressing mice (double-transgenic APP and PSI mouse strains with a 129s6 background), ages 6-8 weeks old, and weighing 20-24 grams were successfully bred in our laboratory. The animals were divided into 5 groups. APP-overexpressing mice and wild-type (WT) mice were pretreated with ETAS (R) 50 powder (50% elemental ETAS and 50% destrin) at 200 mg/kg and 1000 mg/kg body weight. Saline, the vehicle for ETAS (R) 50, was administered in APP-overexpressing mice and WT mice. ETAS (R) 50 and saline were administered by gavage daily for 1 month. Cognitive assessments, using the Morris Water Maze, demonstrated that memory was recovered following ETAS (R) 50 treatment as compared to nontreated APP mice. At euthanization, the brain was removed and HSPs, amyloid beta, tau proteins, and caspase-3 were evaluated through immunofluorescence staining with the appropriate antibodies. Our data indicate that APP mice have cognitive impairment along with elevated amyloid beta, tau proteins, and caspase-3. ETAS (R) 50 restored cognitive function in these transgenic mice, increased both HSP70 and HSP27, and attenuated pathogenic level of amyloid beta, tau proteins, and caspsase-3 leading to neuroprotection. Our results were confirmed with a significant increase in HSP70 gene expression in the hippocampus.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Aβ-dependent alteration in cerebrovascular autoregulation in transgenic mice overexpressing the Amyloid precursor protein
    Niwa, K
    Ashe, KH
    Carlson, G
    Iadecola, C
    STROKE, 2000, 31 (01) : 287 - 287
  • [2] Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
    Maia, Luis F.
    Kaeser, Stephan A.
    Reichwald, Julia
    Hruscha, Michael
    Martus, Peter
    Staufenbiel, Matthias
    Jucker, Mathias
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (194)
  • [3] Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein
    Zhang, FY
    Eckman, C
    Younkin, S
    Hsiao, KK
    Iadecola, C
    JOURNAL OF NEUROSCIENCE, 1997, 17 (20): : 7655 - 7661
  • [4] Impaired neurotransmitter systems by Aβ amyloidosis in APPsw transgenic mice overexpressing amyloid β protein precursor
    Tomidokoro, Y
    Harigaya, Y
    Matsubara, E
    Ikeda, M
    Kawarabayashi, T
    Okamoto, K
    Shoji, M
    NEUROSCIENCE LETTERS, 2000, 292 (03) : 155 - 158
  • [5] Accumulation of amyloid-β protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor
    Fukuchi, KI
    Li, L
    Hart, M
    Lindsey, JR
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2000, 81 (04) : 231 - 239
  • [6] Neurofibrillary pathology in transgenic mice overexpressing V717F β-amyloid precursor protein
    Masliah, E
    Sisk, A
    Mallory, M
    Games, D
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (04): : 357 - 368
  • [7] Behavioral disturbances in transgenic mice overexpressing the V717F β-amyloid precursor protein
    Dodart, JC
    Meziane, H
    Mathis, C
    Bales, KR
    Paul, SM
    Ungerer, A
    BEHAVIORAL NEUROSCIENCE, 1999, 113 (05) : 982 - 990
  • [8] Cerebrovascular dysregulation and increased severity of focal ischemia in transgenic mice overexpressing amyloid precursor protein
    Zhang, FY
    Hsiao, KK
    Iadecola, C
    STROKE, 1997, 28 (01) : 154 - 154
  • [9] Early olfactory axonal guidance defects in transgenic mice overexpressing human amyloid precursor protein
    Albers, MW
    Brown, HEV
    Axel, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S245 - S245
  • [10] Characterization of amyloid β peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein
    Pype, S
    Moechars, D
    Dillen, L
    Mercken, M
    JOURNAL OF NEUROCHEMISTRY, 2003, 84 (03) : 602 - 609